XML 18 R10.htm IDEA: XBRL DOCUMENT

INVESTMENT IN AVAILABLE FOR SALE MARKETABLE SECURITIES	9 Months Ended
Sep. 30, 2023
INVESTMENT IN AVAILABLE FOR SALE MARKETABLE SECURITIES
INVESTMENT IN AVAILABLE FOR SALE MARKETABLE SECURITIES	NOTE 4 - INVESTMENT IN AVAILABLE FOR SALE MARKETABLE SECURITIES The Company’s investment in marketable equity securities is being held for an indefinite period. Cost basis of marketable securities held as of September 30, 2023 and December 31, 2022 were $59,720 and $42,720 and accumulated unrealized losses were $58,320 and $42,720 as of September 30, 2023 and December 31, 2022, respectively. The fair market value of available for sale marketable securities was $1,400 and $0 as of September 30, 2023 and December 31, 2022, respectively, based on 178,000 shares of common stock held in one entity with an average per share market price of approximately $0.00 and 2,000 shares of preferred convertible stock held in another entity with the estimated average value upon conversion into common stock of $1,400, and is included within prepaid expenses and other current assets within accompanying consolidated balance sheet. During the three months ended September 30, 2023, the Company received 2,000 shares initially valued at $17,000 in exchange for $150,000 of accounts receivable which was fully reserved for.

INVESTMENT IN AVAILABLE FOR SALE MARKETABLE SECURITIES

9 Months Ended

Sep. 30, 2023

INVESTMENT IN AVAILABLE FOR SALE MARKETABLE SECURITIES

INVESTMENT IN AVAILABLE FOR SALE MARKETABLE SECURITIES

NOTE 4 - INVESTMENT IN AVAILABLE FOR SALE MARKETABLE SECURITIES

The Company’s investment in marketable equity securities is being held for an indefinite period. Cost basis of marketable securities held as of September 30, 2023 and December 31, 2022 were $59,720 and $42,720 and accumulated unrealized losses were $58,320 and $42,720 as of September 30, 2023 and December 31, 2022, respectively. The fair market value of available for sale marketable securities was $1,400 and $0 as of September 30, 2023 and December 31, 2022, respectively, based on 178,000 shares of common stock held in one entity with an average per share market price of approximately $0.00 and 2,000 shares of preferred convertible stock held in another entity with the estimated average value upon conversion into common stock of $1,400, and is included within prepaid expenses and other current assets within accompanying consolidated balance sheet.

During the three months ended September 30, 2023, the Company received 2,000 shares initially valued at $17,000 in exchange for $150,000 of accounts receivable which was fully reserved for.